Could common cardiovascular medications be putting patients at risk of severe COVID-19?
ACE inhibitors and angiotensin receptor blockers are cardiovascular medications commonly used to treat a variety of diseases, including high blood pressure, heart disease, diabetes, and chronic kidney disease. However, early research indicates that these drugs may contribute to an increased risk of severe COVID-19, should patients taking these medications become infected with the novel COVID-19 virus. In a r… 更多Could common cardiovascular medications be putting patients at risk of severe COVID-19?
ACE inhibitors and angiotensin receptor blockers are cardiovascular medications commonly used to treat a variety of diseases, including high blood pressure, heart disease, diabetes, and chronic kidney disease. However, early research indicates that these drugs may contribute to an increased risk of severe COVID-19, should patients taking these medications become infected with the novel COVID-19 virus. In a recent article published in the Journal of Travel Medicine, researchers from the United States hypothesize that the use of ACE inhibitors and angiotensin receptor blockers may be putting these patients at risk of severe COVID-19 and its associated complications.
shared news
